Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
8 pending office actions • 2 clients • 8 examiners • 7 art units • 0 of 8 (0%) have an AI response strategy ready
Matney Legal Group PLLC focuses on Biotechnology & Pharmaceuticals and has 170 career applications. The profile includes 8 pending office actions, indicating current prosecution activity within the reported application base.
The resolved allowance rate is 94.62%, while allowances involved an average of 3.11 office actions. Most resolved applications therefore reached allowance, although the path commonly included multiple examination actions. These figures give practitioners separate context for outcome expectations and response planning.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| §102 only | 1 (12%) |
| Double-patenting + other | 2 (25%) |
| Multi-statute (no §101) | 4 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BERKE-SCHLESSEL, DAVID W | 1 | 66.8% | +31.5% |
| MCNEIL, JENNIFER C | 1 | 23.7% | +20.0% |
| HERBERT, MADISON TAYLOR | 1 | 59.1% | +53.7% |
| JOHNSON, ALLISON MARIE | 1 | 40.9% | +53.3% |
| ALEMAN, SARAH WEBB | 1 | 62.2% | +23.6% |
| BATES, KEENAN ALEXANDER | 1 | 44.9% | +79.8% |
| STAVROU, CONSTANTINA E | 1 | 42.4% | +35.6% |
| VAN BUREN, LAUREN K | 1 | 40.0% | +58.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17731616 | PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL | JOHNSON, ALLISON MARIE | 62d |
| 18241557 | GLYCOSYLATED STEVIOL GLYCOSIDE COMPOSITIONS AND METHODS OF PREPARING GLYCOSYLATED STEVIOL GLYCOSIDE COMPOSITIONS | MCNEIL, JENNIFER C | — |
| 17987257 | CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES | HERBERT, MADISON TAYLOR | — |
| 17695170 | AORTOILIAC IMPLANT AND PROCESSING AND USES THEREOF | ALEMAN, SARAH WEBB | — |
| 17506140 | MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES | BATES, KEENAN ALEXANDER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17088860 | ICE-FREE VITRIFICATION AND NANO WARMING OF LARGE TISSUE SAMPLES | VAN BUREN, LAUREN K | 72d overdue |
| 17731616 | PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL | JOHNSON, ALLISON MARIE | 62d |
| 18757079 | CROSSLINKED SOFT TISSUE GRAFT AND METHODS OF USE THEREOF | BERKE-SCHLESSEL, DAVID W | — |
| 18241557 | GLYCOSYLATED STEVIOL GLYCOSIDE COMPOSITIONS AND METHODS OF PREPARING GLYCOSYLATED STEVIOL GLYCOSIDE COMPOSITIONS | MCNEIL, JENNIFER C | — |
| 17987257 | CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES | HERBERT, MADISON TAYLOR | — |
| 17695170 | AORTOILIAC IMPLANT AND PROCESSING AND USES THEREOF | ALEMAN, SARAH WEBB | — |
| 17506140 | MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES | BATES, KEENAN ALEXANDER | — |
| 17603661 | BIRTH TISSUE-DERIVED PRODUCTS AND PREPARATION AND USES THEREOF | STAVROU, CONSTANTINA E | — |
| Client (Assignee) | Pending OAs |
|---|---|
| LifeNet Health | 7 |
| Tate & Lyle | 1 |
| Art Unit | Apps |
|---|---|
| 1638 | 2 |
| 1651 | 1 |
| 1793 | 1 |
| 1758 | 1 |
| 3774 | 1 |
| 1631 | 1 |
| 1632 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18757079 | CROSSLINKED SOFT TISSUE GRAFT AND METHODS OF USE THEREOF | Lifenet Health | BERKE-SCHLESSEL, DAVID W | 1651 | §112DP | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18241557 | GLYCOSYLATED STEVIOL GLYCOSIDE COMPOSITIONS AND METHODS OF PREPARING GLYCOSYLATED STEVIOL GLYCOSIDE COMPOSITIONS | Tate & Lyle Solutions Usa LLC | MCNEIL, JENNIFER C | 1793 | §103§112 | Final Rejection | — | Pending | Sep 01, 2023 |
| 17987257 | CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES | Lifenet Health | HERBERT, MADISON TAYLOR | 1758 | §102§103 | Final Rejection | — | Pending | Nov 15, 2022 |
| 17731616 | PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL | Lifenet Health | JOHNSON, ALLISON MARIE | 1638 | §102§103§112 | Non-Final OA | 62d | Pending | Apr 28, 2022 |
| 17695170 | AORTOILIAC IMPLANT AND PROCESSING AND USES THEREOF | Lifenet Health | ALEMAN, SARAH WEBB | 3774 | §101§103 | Final Rejection | — | Pending | Mar 15, 2022 |
| 17506140 | MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES | Lifenet Health | BATES, KEENAN ALEXANDER | 1631 | §103§112 | Non-Final OA | — | Pending | Oct 20, 2021 |
| 17603661 | BIRTH TISSUE-DERIVED PRODUCTS AND PREPARATION AND USES THEREOF | Lifenet Health | STAVROU, CONSTANTINA E | 1632 | §102 | Final Rejection | — | Pending | Oct 14, 2021 |
| 17088860 | ICE-FREE VITRIFICATION AND NANO WARMING OF LARGE TISSUE SAMPLES | Lifenet Health | VAN BUREN, LAUREN K | 1638 | §112DP | Final Rejection | 72d overdue | Pending | Nov 04, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial94.6% of resolved applications prosecuted by Matney Legal Group Pllc were allowed, across 170 applications in USPTO records.
3.11 office actions per allowed application on average.
8 pending office actions as of October 2026, for 2 clients, before 8 examiners in 7 art units.
